Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMLODIPINE vs DILTIAZEM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMLODIPINE vs DILTIAZEM: Safety Overview

Metric AMLODIPINE DILTIAZEM
Total FAERS Reports 64,924 14,726
Deaths Reported 10,161 4,562
Death Rate 15.7% 31.0%
Hospitalizations 26,787 6,674
Average Patient Age 62.8 yrs 67.1 yrs
% Female Patients 57.0% 70.8%
FDA Approval Date Apr 12, 2011 Apr 10, 2003
Manufacturer Teva Pharmaceuticals USA, Inc. Bausch Health US LLC
Route ORAL ORAL
Marketing Status Prescription Prescription